InsiderTrades.com logo

VIRI Insider Trading

Insider Ownership Percentage: 12.20%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $0.00

Virios Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Virios Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Virios Therapeutics Share Price & Price History

Current Price: $6.21
Price Change: ▼ Price Decrease of -0.01 (-0.16%)
As of 12/3/2025 01:00 AM ET

This chart shows the closing price history over time for VIRI up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Virios Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/21/2023William PridgenDirectorBuy15,335$1.30$19,935.5052,045View SEC Filing Icon  
8/17/2023Gregory Scott DuncanCEOBuy25,000$1.25$31,250.0057,461View SEC Filing Icon  
12/8/2022Richard James WhitleyDirectorSell1,800$0.26$468.00700View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Virios Therapeutics (NASDAQ:VIRI)

9.05% of Virios Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at VIRI by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Virios Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/8/2023Belvedere Trading LLC18,142$25K0.0%N/A0.099%Search for SEC Filing on Google Icon
7/28/2023McCollum Christoferson Group LLC30,700$42K0.0%N/A0.168%Search for SEC Filing on Google Icon
11/7/2022Warberg Asset Management LLC200,000$74K0.0%N/A2.401%Search for SEC Filing on Google Icon
10/13/2022PVG Asset Management Corp80,590$31K0.1%N/A0.967%Search for SEC Filing on Google Icon
7/12/2022Koshinski Asset Management Inc.40,924$0.17M0.0%N/A0.491%Search for SEC Filing on Google Icon
7/6/2022Wiley BROS. Aintree Capital LLC11,000$47K0.0%N/A0.132%Search for SEC Filing on Google Icon
5/12/2022Cetera Advisors LLC43,944$0.20M0.0%+22.0%0.528%Search for SEC Filing on Google Icon
11/16/2021Captrust Financial Advisors40,145$0.21M0.0%N/A0.482%Search for SEC Filing on Google Icon
11/16/2021Cetera Advisors LLC48,432$0.26M0.0%+100.0%0.581%Search for SEC Filing on Google Icon
11/16/2021Masters Capital Management LLC650,000$3.44M0.1%+8.3%7.803%Search for SEC Filing on Google Icon
11/9/2021BlackRock Inc.15,856$84K0.0%+64.3%0.190%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Virios Therapeutics logo
Virios Therapeutics, Inc., a development-stage biotechnology company, focuses on developing novel antiviral therapies to treat diseases associated with a viral triggered abnormal immune response. The company's lead development candidate is the IMC-1, a fixed dose combination of famciclovir and celecoxib to treat fibromyalgia. It also develops IMC-2, a combination of valacyclovir and celecoxib for the treatment of managing the fatigue, sleep, attention, pain, autonomic function, and anxiety associated with long COVID. The company was formerly known as Innovative Med Concepts, LLC and changed its name to Virios Therapeutics, Inc. in July 2020. The company was founded in 2012 and is headquartered in Alpharetta, Georgia.
Read More on Virios Therapeutics

Today's Range

Now: $6.21
Low: $6.10
High: $6.26

50 Day Range

MA: $6.09
Low: $5.11
High: $7.91

52 Week Range

Now: $6.21
Low: $0.13
High: $1.04

Volume

39,941 shs

Average Volume

1,049,645 shs

Market Capitalization

$119.59 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.58